Vimentin Antikörper
(1 reference)-
- Target Alle Vimentin (VIM) Antikörper anzeigen
- Vimentin (VIM)
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Vimentin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- This antibody reacts to Vimentin.
- Aufreinigung
- Affinity chromatography
- Immunogen
- Pig eye lens vimentin
- Klon
- VMT-24
- Isotyp
- IgG1
- Top Product
- Discover our top product VIM Primärantikörper
-
anti-Vimentin (VIM) (AA 371-466) antibody
VIM Reaktivität: Human, Maus, Ratte, Schwein, Rind (Kuh), Affe WB, ELISA, FACS, IHC (p), ICC, IHC (fro), IF (p), IF (cc) Wirt: Kaninchen Polyclonal unconjugated
anti-Vimentin (VIM) antibodyKO Validated VIM Reaktivität: Human WB, IHC, ELISA, IF, IHC (p), ICC, IP, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Säugetier WB, FACS, IHC (p), ICC Wirt: Maus Monoclonal VI-01 unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Human, Maus, Ratte, Schwein, Huhn WB, IHC (p), ICC, IP Wirt: Maus Monoclonal VI-10 unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Human, Maus WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB41034 unconjugated
anti-Vimentin (VIM) (AA 1-200) antibodyVIM Reaktivität: Human WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Vimentin (VIM) antibodyVIM Reaktivität: Human WB, IHC, ICC, IP Wirt: Maus Monoclonal C8 unconjugated
anti-Vimentin (VIM) (AA 430-457), (C-Term) antibodyVIM Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB16691 unconjugated
anti-Vimentin (VIM) (AA 41-140) antibodyVIM Reaktivität: Human WB, ELISA, IF, IP Wirt: Maus Monoclonal 3E9 unconjugated
anti-Vimentin (VIM) (AA 2-466) antibodyVIM Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Maus Monoclonal 3A1F2 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Rekonstitution
- Restore with 1.2 % sodium acetate or neutral PBS
- Konzentration
- 0,1 mg/mL
- Buffer
- 1.2 % sodium acetate, with 2 mg BSA and 0.01 mg sodium azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Prior to reconstitution store at -20 °C. Following reconstitution store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
: "Initialization of epithelial cells by tumor cells in a metastatic microenvironment." in: Oncogene, Vol. 39, Issue 12, pp. 2638-2640, (2020) (PubMed).
-
: "Initialization of epithelial cells by tumor cells in a metastatic microenvironment." in: Oncogene, Vol. 39, Issue 12, pp. 2638-2640, (2020) (PubMed).
-
- Target
- Vimentin (VIM)
- Andere Bezeichnung
- Vimentin (VIM Produkte)
- Hintergrund
- The VIM gene was one of many that Gieser and Swaroop (1992) recovered from a subtracted cDNA library for retinal pigment epithelium. Vimentin gene express in human lymphocytes and in Burkitt's lymphoma cells. Vimentin is secreted by activated macrophages. The gene encoding human vimentin is located on the short arm of chromosome 10.Synonyms: VIM
- Gen-ID
- 7431
- NCBI Accession
- NP_003371
- UniProt
- P08670
- Pathways
- Caspase Kaskade in der Apoptose
-
